GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » 3-Year EPS without NRI Growth Rate

Hangzhou Tigermed Consulting Co (SZSE:300347) 3-Year EPS without NRI Growth Rate : 24.30% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co 3-Year EPS without NRI Growth Rate?

Hangzhou Tigermed Consulting Co's EPS without NRI for the three months ended in Dec. 2023 was ¥0.48.

During the past 12 months, Hangzhou Tigermed Consulting Co's average EPS without NRI Growth Rate was -3.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 24.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 31.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Hangzhou Tigermed Consulting Co was 80.20% per year. The lowest was 0.50% per year. And the median was 26.75% per year.


Competitive Comparison of Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate falls into.



Hangzhou Tigermed Consulting Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Hangzhou Tigermed Consulting Co  (SZSE:300347) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Hangzhou Tigermed Consulting Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines